FDA Pulls Another COVID-19 Rapid Antibody Test Over Performance Concerns
Executive Summary
Autobio’s test reportedly only correctly identified half the positive SARS-CoV-2 antibody samples in an NIH evaluation.
You may also be interested in...
Beckman Coulter Addresses COVID-19 Testing From Multiple Angles
The company expects testing for IgM antibodies will be useful in areas where PCR testing is not keeping up with demand.
FDA Pulls Chembio’s Rapid Test As Purge Of ‘Inaccurate’ Antibody Tests Continues
Chembio’s stock opened down 60% the day after the FDA’s decision to revoke its EUA for the first US rapid test for antibodies to SARS-CoV-2.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.